Viloxazine: Pediatric First Approval.

Paediatr Drugs · 2021 · PMC10575801 · PMID 34036533

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

With viloxazine 100 mg, the improvement in ADHD-RS-IV total score did not reach statistical significance relative to that with placebo (− 16.7 vs − 10.5) [ 17 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.